All Business articles – Page 19
-
BusinessFit for repurpose
Drugs that can be used for new indications offer a potentially cheaper pathway – but only if the investors can recoup their costs
-
BusinessUS steel and aluminium tariffs threaten chemical and plastics sectors
Trump administration to levy 25% tariff on steel and 10% on aluminium
-
BusinessBattery builders get the cobalt blues
Demand for battery metals surges on the back of a global appetite for electric vehicles
-
BusinessOutline for Europe’s first waste to methanol plant
Enerkem teams up with AkzoNobel and Air Liquide to turn rubbish into raw materials
-
BusinessIndian court seizes former Ranbaxy owners’ assets
Daiichi Sankyo inches closer to recovering money from Singh brothers
-
BusinessDowDupont names its three new separate businesses
Corteva Agriscience, Dow and DuPont will be what DowDuPont calls the three independent companies it will spin-off by June 2019
-
BusinessTakata settles with US states over faulty airbag inflators
States will forgo the $650m civil penalty in favour of victims
-
BusinessCompany profile: Ellutia
Ellutia takes GC beyond the ‘box-in-the-lab’, with its customised chromatography
-
BusinessChemist caught stealing and dumping cyanide
Merck & Co senior analytical chemist arrested for stealing and then dumping highly toxic substance down a curbside drain
-
BusinessBMS stimulates cancer drug hopes with giant collaboration
Immunooncology pioneer will pay up to $3.6bn in hope Nektar drug will help non-responders
-
BusinessSanofi enters M&A bonanza
French drugmaker strengthens rare diseases portfolio with blood disorder purchases
-
-
BusinessCelgene takes a punt on M&A
Cancer specialist bags Juno therapeutics and Impact Biomedicines
-
BusinessFDA new drug approvals more than doubled in 2017
The FDA approved 46 new drugs last year – the highest number in over two decades – due to factors like streamlined policies at the agency
-
BusinessNon-profit generic drug company created
Intermountain Healthcare is leading an effort in the US to prevent drug shortages and end their skyrocketing prices
-
BusinessDementia slips down pharma agenda
Pfizer, Shire, Acorda and Axovant rethink their neuroscience strategies
-
BusinessTeva to cut 14,000 jobs
Saddled with debt in an increasingly competitive generic drug industry, the Israel-headquartered giant begins a difficult transformation
-
BusinessChemical industry roundup 2017
Economic and political pressure is encouraging industry to become more specialised as certain sectors consolidate
-
BusinessPharmaceuticals roundup 2017
Political influence has strongly shaped industry activity in the past year
-
BusinessSanofi ordered to pull dengue vaccine
Philippines wants French drugmaker to cover immunisation program costs